Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

Stopped early · Phase 2

Conditions studied: Asthma, Allergy, Allergic Rhinitis, Rhinitis, Allergic, Seasonal

In brief

This study will test the effectiveness of an investigational treatment for patients with ragweed-induced asthma, sometimes called fall seasonal asthma. The treatment being tested is a series of anti-ragweed shots. The purpose of the study is to determine whether a short series of injections with Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC) can cause a long-lasting reduction in the symptoms of asthma that are caused by fall hay fever allergies.

Key facts

Study ID
NCT00318747
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
140
Starts
2006-04-01
Expected to finish
2006-11-01
Last updated by the study team
2013-02-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.